References
Dixon B, Campbell DJ, Santamaria JD (2008) Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery. Intensive Care Med DOI 10.1007/s00134-008-1042-7
Royston D, Bidstrup BP, Taylor KM, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet II:1289–1291
Ranucci M, The European Association of Cardiothoracic Anaesthesiologists (EACTA) (2007) Perioperative haemostasis and coagulation management in cardiac surgery: a European survey. Eur J Anaesthesiol Suppl 24(40):1–13
Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJM, Briët E, Büller HR (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947
Mangano DT, Tudor IC, Dietzel C, The Multicenter Study of Perioperative Ischemia Research Group, The Ischemia Research Education Foundation (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353–365
Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J, The Multicenter Study of Perioperative Ischemia Research Group, The Ischemia Research and Education Foundation (2007) Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297:471–479
Author information
Authors and Affiliations
Corresponding author
Additional information
This editorial refers to the article available at: http://dx.doi.org/10.1007/s00134-008-1042-7.
Rights and permissions
About this article
Cite this article
Ranucci, M. Aprotinin and microvascular thrombosis in cardiac surgery. Intensive Care Med 34, 1175–1176 (2008). https://doi.org/10.1007/s00134-008-1043-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-008-1043-6